← Feed
📰 **AbbVie Says Rinvoq Tops Humira In Rheumatoid Arthritis Study **
(RTTNews) - AbbVie Inc. (ABBV) on Tuesday reported positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study, showing that Rinvoq outperformed Humira in treating adults with moderate to severe rheumatoid arthritis.
🔗 https://www.nasdaq.com/articles/abbvie-says-rinvoq-tops-humira-rheumatoid-arthritis-study
#markets #news
(RTTNews) - AbbVie Inc. (ABBV) on Tuesday reported positive topline results from the Phase 3b/4 head-to-head SELECT-SWITCH study, showing that Rinvoq outperformed Humira in treating adults with moderate to severe rheumatoid arthritis.
🔗 https://www.nasdaq.com/articles/abbvie-says-rinvoq-tops-humira-rheumatoid-arthritis-study
#markets #news
2 views